Logo image of IBIO

IBIO INC (IBIO) Stock Analyst Earnings Estimates

NASDAQ:IBIO - Nasdaq - US4510337086 - Common Stock - Currency: USD

0.5942  0 (-0.03%)

After market: 0.5997 +0.01 (+0.93%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
IBIO revenue by date.IBIO revenue by date.
1.88M
-20.68%

-100.00%
225K408K
81.33%
408K
-100.00%
23.256M32.334M
39.04%
EBITDA
YoY % growth
IBIO ebitda by date.IBIO ebitda by date.
-24.67M
14.04%
-27.74M
-12.44%
-15.384M
44.54%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
IBIO ebit by date.IBIO ebit by date.
-27.94M
10.19%
-28.77M
-2.97%
-16.634M
42.18%
-16.604M
0.18%
-18.87M
-13.65%
-23.358M
-23.78%
-27.642M
-18.34%
-30.396M
-9.96%
-30.906M
-1.68%
-11.73M
62.05%
-4.386M
62.61%
Operating Margin
IBIO operating margin by date.IBIO operating margin by date.
-1,486.17%N/A-7,392.89%-4,069.50%-4,625.00%N/AN/AN/AN/A-50.44%-13.56%
EPS
YoY % growth
IBIO eps by date.IBIO eps by date.
-5.71
-73.03%
-11.27
-97.37%
N/A
32.94%
-1.62
78.54%
-1.40
13.52%
-0.68
51.27%
-0.75
-10.45%
-0.78
-2.70%
-0.68
11.84%
-0.24
64.18%
-0.08
66.67%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26
EPS
Q2Q % growth
-0.30
66.79%
-0.20
55.65%
Revenue
Q2Q % growth
102K
-41.71%
EBITDA
Q2Q % growth
N/AN/A
EBIT
Q2Q % growth
-4.59M
-34.64%
N/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.49
30.99%
-0.33-0.16-50.12%
Q2 2025
Q2Q % growth
-0.48 -0.47-0.01-2.30%
Q1 2025
Q2Q % growth
-0.46 -0.490.036.05%
Q4 2024
Q2Q % growth
-0.91
-117.42%
-0.48-0.43-88.99%
Q3 2024
Q2Q % growth
-0.71
93.55%
%
Q4 2023
Q2Q % growth
5.20
365.31%
-8.3613.56162.17%
Q3 2023
Q2Q % growth
-11.00
-633.33%
-7.34-3.66-49.78%
Q2 2023
Q2Q % growth
-3.42
-173.60%
-2.03-1.39-68.49%
Q1 2023
Q2Q % growth
-2.05
-105.00%
-1.89-0.16-8.35%
Q4 2022
Q2Q % growth
-1.96
-3,820.00%
-2.170.219.57%
Q3 2022
Q2Q % growth
-1.50
-50.00%
-1.40-0.10-6.95%
Q2 2022
Q2Q % growth
-1.25
-25.00%
-1.02-0.23-22.55%
Q1 2022
Q2Q % growth
-1.00
20.00%
-1.280.2721.57%
Q4 2021
Q2Q % growth
-0.05
96.08%
%
Q3 2021
Q2Q % growth
-1.00 -1.280.2721.57%
Q2 2021
Q2Q % growth
-1.00
21.57%
-1.020.021.96%
Q1 2021
Q2Q % growth
-1.25 -2.040.7938.73%
IBIO Yearly EPS VS EstimatesIBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 -100 -200 -300
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
102K-102K-100.00%
Q1 2025
Q2Q % growth

-100.00%
%
Q4 2023
Q2Q % growth
204K-204K-100.00%
Q3 2023
Q2Q % growth

-100.00%
204K-204K-100.00%
Q2 2023
Q2Q % growth
510K-510K-100.00%
Q1 2023
Q2Q % growth

-100.00%
612K-612K-100.00%
Q4 2022
Q2Q % growth

-100.00%
102K-102K-100.00%
Q3 2022
Q2Q % growth
1.8M
133.77%
204K1.596M782.35%
Q2 2022
Q2Q % growth

-100.00%
255K-255K-100.00%
Q1 2022
Q2Q % growth
80K
-80.49%
510K-430K-84.31%
Q4 2021
Q2Q % growth
490K
-56.25%
%
Q3 2021
Q2Q % growth
770K
670.00%
816K-46K-5.64%
Q2 2021
Q2Q % growth
710K
129.03%
510K200K39.22%
Q1 2021
Q2Q % growth
410K
272.73%
410K%
Q4 2020
Q2Q % growth
1.12M
40.00%
102K1.018M998.04%
Q3 2020
Q2Q % growth
100K
-81.13%
%
Q2 2020
Q2Q % growth
310K
-52.31%
102K208K203.92%
Q1 2020
Q2Q % growth
110K
120.00%
%
IBIO Yearly Revenue VS EstimatesIBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2031 2032 10M 20M 30M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS13.24% 13.24% 0% 0%
Revenue49.99% 0% 33.33% 33.33%